Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 60.77%41.43B | 30.07%150.22B | 4.25%25.77B | 8.57%115.5B | 10.16%31.52B | 11.38%28.7B | 11.85%30.57B | 0.15%24.72B | 7.19%106.38B | 0.04%28.61B |
| Cost of revenue | 65.05%29.9B | 30.84%107.51B | 3.15%18.11B | 5.63%82.17B | 5.49%22.06B | 11.68%20.53B | 8.70%22.02B | -3.71%17.56B | 8.31%77.79B | -1.38%20.91B |
| Gross profit | 50.65%11.53B | 28.16%42.71B | 6.95%7.65B | 16.56%33.33B | 22.90%9.46B | 10.61%8.16B | 20.85%8.55B | 11.07%7.16B | 4.24%28.59B | 4.13%7.7B |
| Operating expense | 51.98%10.82B | 42.23%39.71B | 10.27%7.12B | 5.95%27.92B | 13.06%7.39B | 0.78%6.59B | 9.07%7.48B | 0.62%6.45B | 6.15%26.35B | -1.49%6.54B |
| Operating profit | 33.02%713M | -44.44%3.01B | -23.65%536M | 141.26%5.41B | 78.36%2.07B | 87.35%1.57B | 396.74%1.07B | 2,320.69%702M | -13.97%2.24B | 53.44%1.16B |
| Net non-operating interest income (expenses) | -10.71%-155M | -188.17%-410M | -284.21%-140M | 155.49%465M | 26.88%203M | 683.33%94M | 820.00%92M | 76M | 116.67%182M | 17.65%160M |
| Non-operating interest income | -13.43%116M | -8.05%560M | 12.61%134M | 96.45%609M | 15.56%208M | 215.22%145M | 204.44%137M | 205.13%119M | 39.01%310M | 7.14%180M |
| Non-operating interest expense | -1.09%271M | 573.61%970M | 537.21%274M | 12.50%144M | -75.00%5M | 50.00%51M | 28.57%45M | 10.26%43M | -7.91%128M | -37.50%20M |
| Net investment income | -49.87%189M | -11.29%723M | -15.09%377M | -6.96%815M | -16.46%66M | -34.93%95M | 162.50%210M | -22.24%444M | 8.15%876M | -20.20%79M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 251M | -90.83%461M | 0 | -5.03%5.03B | -5.42%5.03B | 0 | 0 | 0 | 3,073.03%5.29B | 3,085.39%5.31B |
| Income from associates and other participating interests | -195.00%-95M | -40.63%377M | -27.01%100M | 482.57%635M | 180.00%272M | 44.90%142M | -45.45%84M | -30.46%137M | -82.64%109M | -553.33%-340M |
| Special income (charges) | 18,800.00%187M | 4,217.86%1.21B | -109.09%-1M | 116.97%28M | 90.81%-17M | 425.00%21M | 85.71%13M | 22.22%11M | -585.29%-165M | -1,073.68%-185M |
| Less:Other special charges | -18,800.00%-187M | -4,467.86%-1.28B | 109.09%1M | -3.70%-28M | 342.86%17M | -425.00%-21M | -85.71%-13M | -22.22%-11M | 20.59%-27M | 63.16%-7M |
| Less:Write off | ---- | --70M | ---- | --0 | ---- | ---- | ---- | ---- | --192M | ---- |
| Other non-operating income (expenses) | 5.23%-145M | -280.00%-468M | -293.67%-153M | -52.12%260M | -25.12%158M | -92.17%9M | -89.31%14M | -8.14%79M | 55.14%543M | -4.95%211M |
| Income before tax | 31.34%943M | -61.25%4.9B | -50.48%718M | 39.24%12.64B | 21.63%7.78B | 58.33%1.93B | 174.58%1.48B | 56.93%1.45B | 109.46%9.08B | 467.35%6.39B |
| Income tax | 45.68%523M | -57.63%1.52B | -7.95%359M | 34.53%3.59B | 28.39%2.06B | 49.57%525M | 123.64%615M | -10.96%390M | 103.35%2.67B | 512.98%1.61B |
| Net income | 16.99%420M | -62.69%3.37B | -66.13%359M | 41.18%9.04B | 19.34%5.71B | 61.87%1.41B | 227.65%865M | 118.11%1.06B | 112.12%6.41B | 453.53%4.79B |
| Net income continuous operations | 16.99%420M | -62.69%3.38B | -66.13%359M | 41.20%9.05B | 19.36%5.72B | 61.87%1.41B | 227.65%865M | 118.11%1.06B | 112.12%6.41B | 453.53%4.79B |
| Noncontrolling interests | 124.04%233M | 83.09%617M | 9.47%104M | 53.88%337M | -6.87%122M | -20.00%64M | 600.00%56M | 95M | 18.38%219M | 59.76%131M |
| Net income attributable to the company | -26.77%186M | -68.33%2.76B | -73.65%254M | 40.71%8.71B | 20.03%5.59B | 70.30%1.34B | 217.25%809M | 98.35%964M | 118.24%6.19B | 494.13%4.66B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -26.77%186M | -68.33%2.76B | -73.65%254M | 40.71%8.71B | 20.03%5.59B | 70.30%1.34B | 217.25%809M | 98.35%964M | 118.24%6.19B | 494.13%4.66B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -26.90%3.56 | -68.36%52.59 | -73.58%4.87 | 40.96%166.23 | 20.22%106.74 | 70.35%25.62 | 215.10%15.44 | 100.33%18.43 | 121.34%117.93 | 502.37%88.79 |
| Diluted earnings per share | -26.90%3.56 | -68.36%52.59 | -73.58%4.87 | 40.96%166.23 | 20.18%106.706 | 70.29%25.6118 | 217.01%15.44 | 100.33%18.43 | 121.34%117.93 | 502.66%88.79 |
| Dividend per share | 0 | 0.00%44 | 0 | 22.22%44 | 9.09%24 | 0 | 42.86%20 | 0 | 38.46%36 | 69.23%22 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |